LP-503

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLP-503
Drug Alias NameLP-503
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAlpha-1-antiproteinase modulators
TargetsAlpha-1-antiproteinase
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGuangzhou Lintonpharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Lintonpharm Co Ltd
Inactive CompaniesN/A
Active Indicationsalpha 1-Antitrypsin Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A